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Abstract	  A	  search	  of	  the	  cancer	  literature	  reveals	  the	  strong	  association	  between	  long-­‐term	  nighttime	  shiftwork	  and	  increased	  risk	  of	  breast	  cancer	  in	  female	  workers.	  Since	  2007,	  the	  International	  Agency	  for	  Research	  on	  Cancer	  (IARC)	  has	  categorized	  shiftwork	  as	  “probably	  carcinogenic	  to	  humans”,	  a	  Group	  2A	  carcinogen1.	  Evidence	  from	  epigenetic	  studies	  shows	  that	  differential	  methylation	  of	  genes	  is	  one	  possible	  mechanism	  by	  which	  long-­‐term	  shiftwork	  disrupts	  the	  expression	  patterns	  of	  the	  genes	  responsible	  for	  maintaining	  a	  cancer	  free	  status.	  	  This	  study	  builds	  upon	  the	  work	  initiated	  by	  Zhu	  et	  al	  and	  investigates	  the	  association	  between	  shiftwork	  dependent	  methylation	  of	  the	  NBR2-­‐BRAC1	  promoter	  region	  and	  the	  risk	  of	  breast	  cancer	  in	  female	  nighttime	  shift	  workers.	  Understanding	  the	  effects	  of	  methylation	  in	  the	  NBR2-­‐BRAC1	  region	  is	  important	  because	  these	  genes	  share	  a	  bi-­‐directional	  promoter	  that	  sits	  within	  a	  large	  CpG	  island.	  Unraveling	  the	  significance	  of	  methylation	  in	  this	  region	  will	  provide	  a	  deeper	  understanding	  of	  the	  epigenetic	  factors	  that	  promote	  breast	  cancer	  in	  female	  long-­‐term	  nighttime	  shift	  workers	  and	  possibly	  reveal	  a	  biomarker	  of	  clinical	  significance.	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Introduction	  Gene	  methylation	  is	  one	  of	  many	  epigenetic	  mechanisms	  by	  which	  eukaryotic	  cells	  regulate	  the	  expression	  of	  genes.2	  Methylation	  refers	  to	  the	  addition	  of	  methyl	  groups	  to	  the	  nucleic	  acids	  cytosine	  and	  adenine	  mediated	  by	  a	  family	  of	  enzymes	  known	  as	  DNA	  methyltransferases	  (DNMT)	  which	  occurs	  in	  genomic	  regions	  called	  CpG	  islands2.	  CpG	  islands	  are	  regions	  of	  200	  base	  pairs	  (bp)	  where	  the	  cytosine	  and	  guanine	  content	  is	  greater	  than	  50%	  and	  the	  observed	  CG	  to	  expected	  CG	  ratio	  is	  more	  than	  0.63.	  The	  methylation	  status	  of	  a	  CpG	  sites	  can	  be	  inherited	  or	  influenced	  by	  exposure	  to	  environmental	  stressors	  and	  other	  behavioral	  factors4,5.	  The	  extent	  of	  methylation	  in	  the	  CpG	  regions	  can	  be	  quantified	  as	  hypermethylated	  or	  hypomethylated	  in	  reference	  to	  the	  normal	  methylation	  status	  of	  a	  particular	  region.	  Both	  hypermethylation	  and	  hypomethylation	  can	  detrimentally	  affect	  the	  normal	  balance	  of	  genomic	  expression	  and	  thus	  facilitate	  a	  cellular	  predisposition	  to	  cancer	  or	  other	  diseases.	  Hypermethylation	  is	  known	  to	  specifically	  silence	  the	  expression	  of	  genes	  by	  suppressing	  transcription5.	  A	  review	  of	  the	  literature	  finds	  many	  examples	  where	  differential	  methylation	  status	  is	  an	  important	  factor	  in	  the	  etiology	  of	  a	  variety	  of	  cancers2,5.	  	  	  Researchers	  have	  identified	  various	  environmental	  and	  behavioral	  factors	  that	  can	  disrupt	  the	  methylation	  status	  of	  genes	  and	  subsequently	  adversely	  affect	  individuals.	  Long-­‐term	  nighttime	  shiftwork,	  marked	  by	  exposure	  to	  artificial	  light	  during	  night	  hours,	  is	  an	  environmental	  exposure	  suspected	  to	  be	  responsible	  for	  disrupting	  normal	  methylation	  status	  of	  genes1,4,6.	  Some	  of	  the	  genes	  thought	  to	  be	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differentially	  methylated	  as	  a	  result	  of	  long-­‐term	  nighttime	  shiftwork	  include	  those	  involved	  in	  the	  mediation	  of	  stress	  and	  in	  the	  regulation	  of	  the	  circadian	  rhythm4,6.	  	  	  An	  epigenetic	  analysis	  of	  a	  prospective	  cohort	  of	  female	  workers	  in	  Denmark	  by	  Zhu	  et	  al	  has	  confirmed	  that	  the	  methylation	  status	  of	  a	  wide	  variety	  of	  genes	  changes	  as	  a	  result	  of	  long-­‐term	  nighttime	  shiftwork6.	  Zhu	  et	  al’s	  epigenetic	  study	  of	  long-­‐term	  nighttime	  shift	  workers	  revealed	  the	  differential	  methylation	  status	  of	  many	  genes	  deserving	  further	  study	  for	  possible	  relevance	  to	  cancer	  biology	  and	  other	  health	  conditions.	  	  One	  interesting	  association	  observed	  in	  studies	  of	  long-­‐term	  nighttime	  shift	  workers	  is	  that	  women	  are	  at	  increased	  risk	  of	  breast	  cancer	  compared	  to	  their	  daytime	  counterparts6,7.	  While	  some	  explanations	  for	  the	  increased	  incidence	  in	  breast	  cancer	  amongst	  female	  long-­‐term	  nighttime	  shift	  workers	  have	  been	  suggested,	  no	  definitive	  mechanism	  has	  yet	  been	  discovered.	  This	  study	  is	  interested	  in	  providing	  insight	  into	  the	  possible	  mechanism	  that	  is	  responsible	  for	  increased	  risk	  of	  breast	  cancer	  in	  female	  long-­‐term	  nighttime	  shift	  workers.	  	  	  Building	  upon	  the	  methylation	  study	  by	  Zhu	  et	  al,	  this	  study	  further	  investigates	  the	  association	  between	  methylation	  in	  genes	  associated	  with	  breast	  cancer	  in	  long-­‐term	  nighttime	  shift	  workers.	  Specifically,	  this	  study	  focuses	  on	  the	  region	  of	  the	  tumor	  suppressor	  BRCA1	  (Breast	  Cancer	  1,	  early	  onset)	  and	  its	  neighboring	  gene	  NBR2	  (Neighbor	  of	  BRCA1	  gene	  2)	  because	  these	  two	  genes	  share	  a	  bi-­‐directional	  promoter	  nested	  within	  a	  large	  CpG	  island8.	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The	  tumor	  suppressor	  gene	  BRCA1	  lies	  in	  the	  21q	  arm	  of	  chromosome	  17	  and	  contains	  23	  exons.	  Research	  has	  conclusively	  shown	  that	  BRCA1	  plays	  a	  very	  important	  role	  in	  breast	  cancer	  etiology.	  Some	  of	  the	  functions	  that	  BRCA1	  is	  responsible	  for	  are	  transcription,	  DNA	  repair	  of	  double	  stranded	  breaks	  and	  recombination9.	  The	  study	  of	  mutations	  and	  epigenetic	  modifications	  has	  established	  that	  disruption	  to	  the	  function	  of	  BRCA1	  can	  lead	  to	  adverse	  effects.	  It	  is	  estimated	  that	  mutations	  in	  the	  BRCA1	  gene	  are	  responsible	  for	  50%	  to	  85%	  of	  familial	  breast	  cancers10.	  Epigenetic	  studies	  of	  BRCA1	  have	  also	  found	  evidence	  that	  methylation	  is	  accountable	  for	  cases	  of	  breast	  cancer11.	  A	  range	  of	  studies	  indicate	  that	  methylation	  of	  the	  BRCA1	  promoter	  could	  be	  responsible	  for	  9%-­‐32%	  of	  sporadic	  breast	  cancers12.	  	  	  The	  NBR2	  is	  a	  non-­‐protein	  coding	  gene	  that	  shares	  a	  bi-­‐directional	  promoter	  with	  BRCA113.	  NBR2	  is	  19,531	  base	  pairs	  in	  length	  and	  it	  consists	  of	  5	  exons,	  the	  fifth	  exon	  can	  be	  alternatively	  used14.	  The	  intergenic	  distance	  separating	  NBR2	  and	  the	  transcription	  start	  site	  of	  BRCA1	  is	  only	  218	  bp.	  The	  intergenic	  region	  contains	  cis-­‐elements	  that	  can	  bind	  transcription	  factors	  that	  have	  the	  ability	  to	  function	  uni-­‐directionally	  or	  bi-­‐directionally.	  	  Thus	  the	  regulatory	  activity	  in	  the	  intergenic	  region	  can	  co-­‐regulate	  NBR2	  and	  BRCA1	  in	  a	  spatial	  or	  temporal	  manner	  that	  is	  dependent	  on	  the	  availability	  of	  specific	  regulatory	  factors14.	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  Figure	  113.	  	  Structure	  of	  the	  NBR2-­‐BRCA1	  locus.	  This	  figure	  shows	  the	  shared	  bi-­‐directional	  promoter	  and	  the	  CpG	  island.	  M+	  represents	  the	  methylated	  domain	  of	  the	  CpG	  island.	  The	  intergenic	  region	  between	  the	  first	  exon	  of	  NBR2	  and	  the	  transcription	  start	  site	  is	  218	  bp.	  Note	  that	  the	  intergenic	  region	  lies	  within	  the	  site	  labeled	  promoter.	  Interestingly,	  the	  bi-­‐directional	  promoter	  shared	  by	  NBR2	  and	  BRAC1	  sits	  within	  a	  large	  CpG	  island	  that	  is	  found	  to	  be	  methylated	  in	  most	  human	  tissues13,	  making	  this	  region	  an	  interesting	  site	  for	  epigenetic	  study.	  The	  CpG	  island	  spans	  approximately	  2.8	  kb	  in	  length	  and	  it	  extends	  1810	  bases	  downstream	  and	  870	  bases	  upstream	  from	  the	  start	  of	  the	  BRCA1	  transcription	  site.	  However,	  the	  methylated	  domain	  (M+	  in	  figure	  1)	  of	  the	  CpG	  island	  lies	  about	  1	  Kb	  from	  the	  promoter	  site	  that	  regulates	  the	  expression	  of	  NBR2	  and	  BRCA1.	  An	  in	  vitro	  study	  using	  human	  cell	  lines	  found	  that	  chemically	  induced	  demethylation	  of	  the	  CpG	  island	  increased	  the	  expression	  of	  NBR2	  3.1	  fold	  and	  BRCA1	  1.8	  fold13.	  The	  results	  indicate	  that	  methylation	  of	  the	  CpG	  island,	  even	  when	  not	  concentrated	  in	  the	  region	  of	  the	  shared	  promoter,	  can	  exert	  a	  degree	  of	  influence	  on	  the	  expression	  of	  NBR2	  and	  BRCA1.	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Understanding	  the	  regulatory	  effects	  of	  methylation	  in	  the	  region	  of	  the	  shared	  promoter	  of	  NBR2-­‐BRCA1	  is	  important	  because	  we	  have	  found	  evidence	  that	  this	  region	  is	  highly	  methylated	  in	  long-­‐term	  nighttime	  shift	  workers	  who	  are	  also	  at	  higher	  risk	  of	  breast	  cancer	  than	  female	  daytime	  workers.	  It	  is	  possible	  that	  methylation	  of	  shared	  promoter	  is	  the	  mechanism	  by	  which	  nighttime	  shiftwork	  mediates	  the	  observed	  increased	  risk	  of	  breast	  caner.	  	  	  
Methods	  
Study Population6 Our	  study	  is	  based	  on	  the	  Danish	  “Diet,	  Cancer	  and	  Health”	  prospective	  cohort,	  established	  between	  December	  1993	  and	  May	  1997.	  All	  female	  participants	  were	  born	  in	  Denmark,	  free	  of	  any	  cancer	  and	  aged	  between	  50	  and	  64	  years	  at	  time	  of	  invitation	  (now	  between	  65	  and	  79	  years	  old).	  The	  baseline	  questionnaire	  included	  questions	  on	  food	  consumption,	  folate	  intake,	  other	  lifestyle	  factors	  (e.g.,	  tobacco	  smoking,	  alcohol	  habits,	  sun	  exposure,	  physical	  activity,	  and	  medical	  anamnesis),	  reproductive	  factors,	  education	  and	  occupation.	  All	  participants	  gave	  written	  informed	  consent.	  All	  collected	  biological	  samples	  were	  frozen	  and	  kept	  at	  -­‐150	  ºC15.	  The	  season	  of	  blood	  collection	  did	  not	  differ	  between	  night	  shift	  workers	  and	  day	  workers	  (P	  =	  0.162).	  Information	  on	  the	  characteristics	  of	  the	  study	  subjects	  is	  provided	  in	  Table	  1.	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Table 1.  Description of subject characteristics1,2 
 
Characteristic Day workers (n = 10) 




Age (years) 54.0 ± 3.3 54.8 ± 3.6 0.610 
Folate intake (µg/day) 373.1 ± 108.4 349.9 ± 125.1 0.664 
Tobacco smoking (years) 17.7 ± 15.2 18.0 ± 17.6 0.968 
Cumulative alcohol intake (g) 93,877.4 ± 68,517.9 114,622.9 ± 62,902.0 0.490 
Hormone replacement therapy 
(years) 
2.8 ± 4.8 3.65 ± 4.0 0.673 
Years of shiftwork 0 ± 0.0 21.2 ± 8.8 <0.001 
1Tables values are given as mean ± SD. 
2All subjects are female and of non-Hispanic ethnicity. 
3P-value of independent t-test. 	  	  
Collection	  of	  Shiftwork	  Information6	  Night	  work	  was	  defined	  as	  having	  worked	  fulltime	  between	  7	  pm	  and	  9	  am.	  Information	  on	  night	  shiftwork	  status	  was	  obtained	  by	  telephone	  interview.	  All	  study	  subjects	  were	  classified	  into	  3	  groups:	  women	  with	  10+	  years	  of	  night	  shiftwork,	  women	  with	  <10	  years	  of	  night	  shiftwork,	  and	  daytime	  workers.	  	  	  
Collection	  of	  Folate	  Intake	  Information6	  Folate	  intake	  data	  were	  collected	  at	  baseline	  using	  a	  192-­‐item	  food-­‐frequency	  questionnaire	  mailed	  to	  each	  participant.	  12	  categories,	  from	  “never”	  to	  “eight	  times	  or	  more	  per	  day”,	  were	  used	  to	  estimate	  the	  average	  intake	  of	  each	  food	  item	  during	  the	  last	  12	  months.	  Open-­‐ended	  questions	  were	  designed	  for	  supplement	  use	  on	  brands	  and	  doses.	  Information	  on	  folate	  content	  in	  each	  supplement	  brand	  was	  obtained	  from	  producers	  or	  distributors.	  For	  each	  participant,	  average	  daily	  folate	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intake	  was	  calculated	  using	  the	  software	  program	  Food	  Calc	  (www.ibt.ku.dk/jesper/foodcalc)	  as	  total,	  dietary,	  and	  supplemental	  intake.	  	  	  
Genome-­‐Wide	  CpG	  Island	  Methylation	  Assay6	  10	  pairs	  of	  long-­‐term	  night	  shiftworkers	  and	  day	  workers	  were	  selected	  from	  the	  study	  population	  matched	  by	  age	  (±2	  years)	  and	  total	  folate	  intake	  (±55μg/day).	  Genomic	  DNA	  was	  isolated	  and	  purified	  from	  blood	  samples	  using	  the	  QIAamp	  DNA	  Blood	  Mini	  Kit	  (Qiagen)	  according	  to	  the	  manufacturer’s	  protocol.	  50	  ng	  of	  genomic	  DNA	  per	  sample	  were	  bisulfite	  treated	  using	  the	  EZ	  DNA	  Methylation	  Kit	  (Zymo	  research)	  according	  to	  the	  manufacturer’s	  protocol.	  CpG	  island	  methylation	  of	  miRNA	  promoter	  regions	  was	  determined	  using	  the	  Illumina	  Infinium	  Methylation	  Assay,	  covering	  255	  CpG	  sites	  of	  110	  microRNAs.	  A	  methylation	  index	  (β)	  was	  used	  to	  estimate	  the	  methylation	  level	  of	  each	  CpG	  locus	  using	  the	  ratio	  of	  intensities	  between	  methylated	  and	  unmethylated	  cytosines,	  which	  is	  a	  continuous	  variable	  between	  0	  and	  1.	  0	  corresponds	  to	  a	  completely	  unmethylated	  site,	  while	  1	  corresponds	  to	  a	  completely	  methylated	  site.	  	  	  Methylation	  was	  calculated	  by	  use	  of	  Illumina	  GenomeStudio	  Software.	  The	  shift	  differential	  score	  provides	  a	  metric	  to	  judge	  the	  extent	  of	  methylation	  relative	  to	  a	  control.	  In	  this	  study	  shift	  workers	  were	  the	  comparison	  group	  and	  day	  workers	  were	  used	  as	  a	  reference	  group.	  The	  shift	  differential	  score	  can	  be	  converted	  by	  taking	  the	  average	  difference	  of	  the	  signal	  in	  the	  reference	  group	  vs.	  the	  average	  signal	  in	  the	  comparison	  group	  (p	  =	  10'(DiffScore*sgn(µcond-­‐µref)/10)). A	  shift	  
	   12	  
differential	  score	  of	  +/-­‐	  13	  is	  considered	  to	  be	  statistically	  significant	  at	  the	  alpha	  level	  of	  0.0516.	  The	  greater	  the	  magnitude	  of	  the	  shift	  differential	  scores	  the	  greater	  the	  statistical	  significance	  of	  the	  results.	  Also,	  a	  positive	  shift	  differential	  score	  refers	  to	  hypermethylation	  while	  a	  negative	  score	  is	  indicative	  of	  hypomethylation.	  The	  results	  yielded	  a	  list	  from	  which	  the	  100	  most	  significantly	  hypermethylated	  and	  hypomethylated	  CpG	  sites	  were	  selected	  for	  further	  analysis.	  	  	  From	  the	  list	  of	  the	  100	  most	  significantly	  hypermethylated	  and	  hypomethylated	  genes,	  we	  selected	  a	  smaller	  set	  of	  genes	  if	  they	  were	  located	  in	  relative	  proximity	  to	  the	  first	  exon	  or	  were	  located	  within	  an	  active	  promoter	  regions	  in	  7	  of	  9	  cell	  lines.	  We	  also	  selected	  genes	  with	  post-­‐transcriptional	  regulatory	  function	  if	  they	  were	  located	  near	  selected	  methylation	  sites.	  The	  final	  list	  of	  candidate	  genes	  included	  NBR2	  and	  BRCA1.	  	  We	  also	  investigated	  the	  location	  of	  the	  methylated	  CpG	  sites	  for	  NBR2	  and	  BRCA1	  using	  the	  University	  of	  California	  Santa	  Cruz’s	  (UCSC)	  Genome	  Browser.	  We	  queried	  the	  location	  of	  four	  significantly	  methylated	  CpG	  sites,	  2	  sites	  for	  NBR2	  and	  2	  sites	  for	  BRCA1	  using	  the	  location	  identifier	  provided	  by	  Illumina	  (NCBI	  genome	  assembly	  version	  36).	  	  Table	  2	  provides	  a	  summary	  of	  the	  4	  significantly	  methylated	  probes	  in	  the	  NBR2-­‐BRCA1	  region.	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Table	  2.	  Methylation	  of	  NBR2	  and	  BRCA1	  CpG	  probes.	  



















β1)	  NBR2	  cg20760063*	   0.063	   0.179	   0.116	   BRCA1	  cg19088651*	   0.108	   0.162	   0.054	  NBR2	  cg10893007*	   0.042	   0.101	   0.059	   BRCA1	  cg04658354*	   0.050	   0.083	   0.034	  	   	   	   	   	  	   BRCA1	   cg19531713	   0.096	   0.119	   0.023	  	   	   	   	   	  	   BRCA1	   cg08993267	   0.091	   0.095	   0.004	  	   	   	   	   	  	   BRCA1	   cg14048487	   0.784	   0.784	   0.000	  	   	   	   	   	  	   BRCA1	   cg11964474	   0.773	   0.755	   -­‐0.017	  	   	   	   	   	  	   BRCA1	   cg06973652	   0.735	   0.715	   -­‐0.020	  	   	   	   	   	  	   BRCA1	   cg07054526	   0.862	   0.841	   -­‐0.021	  	  	   	  	   	  	   	  	   	  	   BRCA1	   cg27383744	   0.800	   0.759	   -­‐0.042	  *Significantly	  methylated	  site	  	  The	  first	  NBR2	  methylation	  probe	  (cg20760063)	  lies	  on	  chromosome	  17,	  position	  38,531,106,	  which	  is	  in	  the	  shared	  promoter	  of	  region	  BRCA1	  and	  NBR2.	  The	  second	  NBR2	  probe	  (cg1089300)	  was	  also	  significantly	  methylated,	  however	  the	  location	  of	  this	  probe	  was	  within	  the	  NBR2	  gene	  and	  not	  within	  the	  promoter	  region.	  The	  two	  BRCA1	  methylation	  probes	  (cg19088651	  and	  cg04658354)	  were	  highly	  methylated	  but	  both	  probes	  lay	  outside	  of	  the	  shared	  promoter	  region.	  	  	  In	  the	  initial	  iteration	  of	  this	  project	  we	  had	  intended	  to	  make	  use	  of	  public	  gene	  expression	  databases,	  however	  after	  exploring	  these	  resources	  we	  decided	  not	  to	  utilize	  them	  for	  a	  number	  of	  reasons.	  One	  problem	  was	  the	  lack	  of	  publicly	  available	  gene	  expression	  data	  of	  BRCA1	  in	  shift	  workers.	  However,	  the	  primary	  problem	  was	  the	  inconsistent	  nature	  of	  the	  BRCA1	  gene	  expression	  information	  available.	  Some	  studies	  have	  observed	  an	  over-­‐expression	  of	  BRCA1,	  while	  others	  find	  it	  to	  be	  under-­‐expressed,	  very	  few	  studies	  provide	  information	  on	  whether	  methylation	  or	  mutation	  was	  the	  mechanism	  affecting	  the	  expression	  results.	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Results	  The	  results	  from	  Zhu’s	  methylation	  study	  showed	  that	  NBR2	  and	  BRCA1	  were	  hypermethylated	  in	  blood	  samples	  from	  female	  long-­‐term	  shift	  workers	  in	  comparison	  to	  their	  daytime	  counterparts.	  The	  shift	  differential	  scores	  in	  the	  two	  NBR2	  probes	  were	  123.	  744	  and	  48.860.	  Since	  the	  shift	  differential	  scores	  for	  both	  of	  the	  NBR2	  sites	  exceed	  the	  value	  of	  13	  and	  are	  positive,	  we	  can	  be	  confident	  that	  both	  of	  these	  locations	  are	  hypermethylated	  relative	  to	  the	  reference	  control	  sample.	  Table	  3	  shows	  a	  summary	  of	  the	  significantly	  methylated	  NBR2	  and	  BRCA1	  probes.	  	   Table	  3.	  Most	  highly	  metylated	  CpG	  sites	  for	  NBR2	  and	  BRCA1	  	  




Gene	   CpG	  Site	  
Shift	  
Differential	  
Score	  NBR2*	   cg20760063	   123.744	   BRCA1	   cg19088651	   25.606	  NBR2	   cg10893007	   48.860	   BRCA1	   cg04658354	   16.842	  *	  Location	  within	  the	  shared	  promoter	  site	   	   	  	  As	  we	  have	  stated	  previously,	  hypermethylation	  in	  the	  promoter	  region	  of	  genes	  is	  a	  mechanism	  that	  is	  known	  to	  silence	  the	  expression	  of	  genes.	  Therefore	  we	  would	  expect	  that	  in	  female	  long-­‐term	  shift	  workers	  expression	  of	  BRCA1	  would	  be	  significantly	  lower	  than	  its	  expression	  in	  daytime	  workers.	  However,	  we	  cannot	  offer	  evidence	  of	  this	  due	  to	  lack	  of	  expression	  data.	  	  	  We	  found	  interesting	  results	  when	  we	  investigated	  the	  location	  of	  the	  NBR2	  and	  BRCA1	  CpG	  sites	  with	  UCSC’s	  Genome	  Browser.	  The	  location	  of	  the	  NBR2	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methylation	  probe	  (cg20760063)	  within	  the	  region	  of	  the	  shared	  promoter	  is	  important	  because	  this	  site	  can	  influence	  the	  expression	  of	  BRCA1.	  Some	  studies	  have	  found	  evidence	  that	  methylation	  in	  the	  BRCA1	  promoter	  site	  can	  silence	  expression	  of	  BRCA1	  in	  breast	  cancer	  tissues17,11,18	  and	  thus	  our	  finding	  that	  samples	  from	  female	  long-­‐term	  shift	  workers	  are	  hypermethylated	  in	  the	  same	  region	  offers	  a	  possible	  means	  by	  which	  we	  can	  explain	  why	  our	  population	  of	  female	  nighttime	  shift	  workers	  is	  at	  higher	  risk	  of	  developing	  breast	  cancer	  than	  female	  daytime	  workers.	  	  	  	  It	  is	  interesting	  to	  note	  that	  of	  the	  9	  BRCA1	  CpG	  methylation	  probes,	  2	  were	  significantly	  methylated	  but	  not	  in	  the	  region	  of	  the	  shared	  promoter.	  The	  rest	  of	  the	  probes	  in	  the	  methylation	  panel	  were	  not	  significantly	  methylated	  and	  they	  did	  not	  rest	  within	  the	  regulatory	  site.	  Further	  research	  must	  be	  conducted	  to	  determine	  the	  significance	  of	  this	  finding	  and	  how	  the	  overall	  methylation	  status	  of	  the	  BRCA1	  gene	  affects	  our	  hypothesis.	  	  
	  
Discussion	  While	  the	  literature	  regarding	  the	  specific	  role	  of	  NBR2	  in	  cancer	  is	  lacking,	  there	  is	  sufficient	  evidence	  to	  warrant	  further	  study	  of	  NBR2-­‐BRCA1	  promoter	  region	  because	  of	  the	  sheer	  amount	  of	  evidence	  establishing	  the	  role	  of	  BRCA1	  in	  breast	  cancer.	  Zhu	  and	  other	  researchers	  have	  found	  that	  female	  long-­‐term	  nightshift	  workers	  are	  at	  higher	  risk	  of	  developing	  breast	  cancer	  compared	  to	  their	  daytime	  counterparts.	  Our	  hypothesis	  is	  that	  hypermethylation	  of	  the	  shared	  NBR2-­‐BRCA1	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promoter	  may	  be	  responsible	  for	  the	  increased	  incidence	  in	  breast	  cancer	  in	  female	  long-­‐term	  nighttime	  shift	  workers.	  	  	  	  To	  confirm	  our	  hypothesis	  that	  hypermethylation	  of	  the	  NBR2-­‐BRCA1	  promoter	  region	  mediates	  the	  risk	  breast	  cancer	  in	  female	  long-­‐term	  nighttime	  shift	  workers	  we	  plan	  on	  investigating	  the	  methylation	  of	  the	  NBR2-­‐BRCA1	  region	  in	  breast	  tissues	  from	  female	  nighttime	  shift	  workers.	  We	  suspect	  to	  find	  similar	  hypermethylation	  in	  the	  region	  as	  we	  did	  in	  blood	  tissues.	  	  	  	  If	  breast	  tissue	  samples	  from	  female	  long-­‐term	  nighttime	  shift	  workers	  are	  confirmed	  to	  be	  hypermethylated	  relative	  to	  daytime	  controls	  it	  would	  be	  reasonable	  to	  expect	  decreased	  levels	  of	  expression	  of	  BRCA1	  relative	  to	  controls.	  Other	  studies	  have	  confirmed	  that	  hypermethylation	  in	  the	  NBR2-­‐BRCA1	  shared	  bi-­‐directional	  promoter	  regions	  leads	  to	  silencing	  of	  BRCA1	  expression	  and	  we	  suspect	  to	  find	  similar	  results	  when	  we	  investigate	  the	  expression	  of	  BRCA1	  in	  long-­‐term	  nighttime	  shift	  workers.	  	  	  	  The	  methylation	  and	  expression	  profiles	  in	  breast	  tissues	  from	  shift	  workers	  can	  be	  explored	  in	  Dr.	  Zhu’s	  laboratory	  using	  quantitative	  real-­‐time	  PCR	  (qRT-­‐PCR)	  techniques.	  qRT-­‐PCR	  is	  a	  quick	  and	  simple	  method	  for	  investigating	  the	  expression	  of	  selected	  genes	  relative	  to	  a	  stable	  set	  of	  controls	  known	  as	  housekeeping	  genes.	  If	  qRT-­‐PCR	  finds	  that	  breast	  tissue	  samples	  that	  are	  hypermethylated	  in	  the	  NBR2-­‐BRCA1	  promoter	  region	  under-­‐express	  the	  BRCA1	  gene	  relative	  to	  non-­‐
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hypermethylated	  controls,	  then	  this	  would	  provide	  compelling	  evidence	  that	  our	  hypothesis	  is	  correct.	  	  	  I	  believe	  that	  this	  study	  has	  found	  an	  important	  clue	  to	  help	  explain	  why	  female	  long-­‐term	  nighttime	  shift	  workers	  experience	  higher	  risk	  of	  breast	  cancer	  relative	  to	  daytime	  workers.	  Hypermethylation	  of	  the	  NBR2-­‐BRCA1	  shared	  bi-­‐directional	  promoter	  region	  could	  be	  the	  mediating	  factor	  for	  increased	  risk	  of	  breast	  cancer	  in	  female	  long-­‐term	  nighttime	  shift	  workers.	  Further	  study	  of	  this	  region	  is	  needed	  to	  confirm	  our	  hypothesis	  that	  hypermethylation	  of	  the	  shared	  promoter	  may	  be	  responsible	  for	  the	  increased	  risk	  of	  breast	  cancer	  through	  silencing	  of	  the	  BRCA1	  tumor	  suppressor	  gene.	  	  	  It	  is	  also	  possible	  that	  the	  hypermethylation	  of	  the	  NBR2-­‐BRCA1	  shared	  promoter	  region	  observed	  in	  blood	  samples	  from	  female	  long-­‐term	  shift	  workers	  could	  serve	  as	  an	  important	  biomarker	  once	  confirmation	  for	  the	  hypermethylation	  status	  of	  breast	  tissues	  is	  provided.	  If	  blood	  samples	  can	  serve	  as	  reliable	  proxies	  for	  breast	  tissues	  then	  our	  findings	  can	  provide	  the	  basis	  for	  a	  non-­‐invasive	  diagnostic	  screening	  method.	  	  	  This	  thesis	  is	  a	  continuation	  of	  professor	  Zhu’s	  methylation	  study	  of	  long-­‐term	  shift	  workers.	  We	  furthered	  his	  work	  by	  finding	  a	  specific	  locus	  that	  functions	  in	  the	  regulation	  of	  the	  tumor	  suppressor	  BRCA1	  and	  we	  provide	  a	  hypothesis	  that	  hypermethylation	  of	  this	  region	  is	  in	  part	  responsible	  for	  mediating	  an	  increased	  
	   18	  
risk	  of	  breast	  cancer	  in	  female	  long-­‐term	  nighttime	  shift	  workers.	  This	  work	  is	  an	  important	  step	  towards	  providing	  a	  mechanism	  to	  explain	  why	  long-­‐term	  nighttime	  shift	  work	  leads	  to	  adverse	  health	  outcomes.	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